Clinical Trials in Atlanta

Showing 10961-10980 of 19,805 trials

A Study to Investigate the Efficacy and Safety of Lusutrombopag (S-888711) Tablets Administered to Adults With Immune Thrombocytopenia (ITP)

NCT01054443

The primary objective of this study was to assess the efficacy of 3 dose levels of lusutrombopag (0.5 mg, 0.75 mg, and 1.0 mg) and placebo on platelet count.

Immune Thrombocytopenia (ITP)

Shionogi20 participantsStarted Mar 2010

Anaheim, California, United States • Los Angeles, California, United States • Washington D.C., District of Columbia, United States +16 more locations

COMPLETED< 1 mile

Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH

NCT03888365

This is an observational, multicenter, single-day, Phase 2 study. This study will include a 14-day Screening Period and Study Day 1 clinic visit. Participants will be required to perform an activity to induce symptoms of PAH, and participants' severity of self-reported symptoms of PAH will be measured from pre-activity, immediately after the activity, and through the 30-minute recovery. Participants will be asked about their PAH symptoms using 3 PGI-S questions that address their overall PAH symptoms, shortness of breath, and physical fatigue.

Pulmonary Arterial Hypertension

United Therapeutics43 participantsStarted Apr 2019

Birmingham, Alabama, United States • Beverly Hills, California, United States • Santa Barbara, California, United States +7 more locations

A Study to Investigate the Efficacy and Safety of Lusutrombopag (S-888711) Tablets Administered to Adults With Immune Thrombocytopenia (ITP)

Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH

Find Trials by Condition in Atlanta

KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)

Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza

A Study to Assess Safety and Efficacy of Risankizumab Using a New Formulation in Participants With Moderate to Severe Plaque Psoriasis

ADVATE Post Authorization Safety Surveillance

Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease

A Study to Assess the Efficacy and Safety of ETC-1002 in Subjects With Elevated Blood Cholesterol and Either Normal or Elevated Triglycerides

Mucopolysaccharidosis (MPS) I, II, and VI Screening in a High-Risk Population With Previous Surgical Repair or Presence of Inguinal and/or Umbilical Hernia in Combination With Pediatric ENT Surgery (The HATT Project)

A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease

Short Term Observational Study in DEB Patients

Ceprotin Treatment Registry

Study of Recombinant Factor IX Product, IB1001, in Previously Treated Pediatric Subjects With Hemophilia B

Early Elimination of Premature Ventricular Contractions in Heart Failure

SynCardia 70cc TAH-t for Destination Therapy (DT)

Post-Market Study of the 3DKnee™ System

Natural History Study of Children With Metachromatic Leukodystrophy

A Controlled Trial of Losartan in Posttraumatic Stress Disorder

Mortality Reduction After Oral Azithromycin: Morbidity Study

ABT-751 With Chemotherapy for Relapsed Pediatric ALL